We demonstrate that the a. chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKgamma/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation.

Brodeur, S.r., Angelini, F., Bacharier, L.b., Blom, A.m., Mizoguchi, E., Fujiwara, H., et al. (2003). C4b-binding protein (C4BP) activates B cells through the CD40 receptor. IMMUNITY, 18(6), 837-848 [10.1016/S1074-7613(03)00149-3].

C4b-binding protein (C4BP) activates B cells through the CD40 receptor

ANGELINI, FEDERICA;
2003-06-01

Abstract

We demonstrate that the a. chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKgamma/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation.
Campo DC Valore Lingua
dc.authority.academicField2000 Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA it
dc.authority.ancejournal IMMUNITY -
dc.authority.isicrui Immunologia it
dc.authority.people Brodeur S. R. -
dc.authority.people ANGELINI, FEDERICA it
dc.authority.people Bacharier L. B. -
dc.authority.people Blom A. M. -
dc.authority.people Mizoguchi E. -
dc.authority.people Fujiwara H. -
dc.authority.people Plebani A. -
dc.authority.people Notarangelo L. D. -
dc.authority.people Dahlback B. -
dc.authority.people Tsitsikov E. -
dc.authority.people Geha R. S. -
dc.cilea.antefix yes it
dc.cilea.autoapproval Questa scheda non e' stata ancora verificata e potrebbe quindi contenere imprecisioni. Scheda pubblicata automaticamente il Thu Mar 15 18:45:20 CET 2012 -
dc.collection.id.s e291c0df-b2a9-cddb-e053-3a05fe0aa144 *
dc.collection.name 01 - Articolo su rivista *
dc.contributor.appartenenza Dipartimento di Medicina dei sistemi *
dc.contributor.appartenenza.mi 7081 *
dc.contributor.area AREA MIN. 06 - Scienze mediche *
dc.date.accessioned 2012/03/15 18:45:21 -
dc.date.available 2012/03/15 18:45:21 -
dc.date.issued 2003-06 -
dc.description.abstracteng We demonstrate that the a. chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKgamma/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation. -
dc.description.allpeople Brodeur, Sr; Angelini, F; Bacharier, Lb; Blom, Am; Mizoguchi, E; Fujiwara, H; Plebani, A; Notarangelo, Ld; Dahlback, B; Tsitsikov, E; Geha, Rs -
dc.description.allpeopleoriginal Brodeur S.R., Angelini F., Bacharier L.B., Blom A.M., Mizoguchi E., Fujiwara H., Plebani A., Notarangelo L.D., Dahlback B., Tsitsikov E., Geha R.S. it
dc.description.fulltext none en
dc.description.numberofauthors 11 -
dc.identifier.citation Brodeur, S.r., Angelini, F., Bacharier, L.b., Blom, A.m., Mizoguchi, E., Fujiwara, H., et al. (2003). C4b-binding protein (C4BP) activates B cells through the CD40 receptor. IMMUNITY, 18(6), 837-848 [10.1016/S1074-7613(03)00149-3]. it
dc.identifier.doi 10.1016/S1074-7613(03)00149-3 it
dc.identifier.isi WOS:000183767700013 -
dc.identifier.scopus 2-s2.0-0038503986 -
dc.identifier.uri http://hdl.handle.net/2108/57263 -
dc.language.iso eng it
dc.relation.firstpage 837 it
dc.relation.issue 6 it
dc.relation.lastpage 848 it
dc.relation.volume 18 it
dc.subject.keywordseng binding protein; CD40 ligand; CD86 antigen; complement component C4b binding protein; I kappa B kinase; I kappa B kinase gamma; immunoglobulin E; intercellular adhesion molecule 1; interleukin 4; protein; unclassified drug; alpha chain; antigen binding; article; B lymphocyte activation; binding site; cellular distribution; controlled study; human; human cell; human tissue; lymphocyte proliferation; priority journal; protein expression; protein function; protein localization; protein protein interaction; tonsil; upregulation; Antigens, CD; Antigens, CD40; Antigens, Differentiation; B-Lymphocytes; Carrier Proteins; Cell Adhesion Molecules; Cell Division; Complement Inactivator Proteins; Glycoproteins; Humans; Immunoglobulin E; Intercellular Adhesion Molecule-1; Interleukin-4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Tonsil; Up-Regulation -
dc.subject.singlekeyword binding protein *
dc.subject.singlekeyword CD40 ligand *
dc.subject.singlekeyword CD86 antigen *
dc.subject.singlekeyword complement component C4b binding protein *
dc.subject.singlekeyword I kappa B kinase *
dc.subject.singlekeyword I kappa B kinase gamma *
dc.subject.singlekeyword immunoglobulin E *
dc.subject.singlekeyword intercellular adhesion molecule 1 *
dc.subject.singlekeyword interleukin 4 *
dc.subject.singlekeyword protein *
dc.subject.singlekeyword unclassified drug *
dc.subject.singlekeyword alpha chain *
dc.subject.singlekeyword antigen binding *
dc.subject.singlekeyword article *
dc.subject.singlekeyword B lymphocyte activation *
dc.subject.singlekeyword binding site *
dc.subject.singlekeyword cellular distribution *
dc.subject.singlekeyword controlled study *
dc.subject.singlekeyword human *
dc.subject.singlekeyword human cell *
dc.subject.singlekeyword human tissue *
dc.subject.singlekeyword lymphocyte proliferation *
dc.subject.singlekeyword priority journal *
dc.subject.singlekeyword protein expression *
dc.subject.singlekeyword protein function *
dc.subject.singlekeyword protein localization *
dc.subject.singlekeyword protein protein interaction *
dc.subject.singlekeyword tonsil *
dc.subject.singlekeyword upregulation *
dc.subject.singlekeyword Antigens *
dc.subject.singlekeyword CD *
dc.subject.singlekeyword Antigens *
dc.subject.singlekeyword CD40 *
dc.subject.singlekeyword Antigens *
dc.subject.singlekeyword Differentiation *
dc.subject.singlekeyword B-Lymphocytes *
dc.subject.singlekeyword Carrier Proteins *
dc.subject.singlekeyword Cell Adhesion Molecules *
dc.subject.singlekeyword Cell Division *
dc.subject.singlekeyword Complement Inactivator Proteins *
dc.subject.singlekeyword Glycoproteins *
dc.subject.singlekeyword Humans *
dc.subject.singlekeyword Immunoglobulin E *
dc.subject.singlekeyword Intercellular Adhesion Molecule-1 *
dc.subject.singlekeyword Interleukin-4 *
dc.subject.singlekeyword NF-kappa B *
dc.subject.singlekeyword p38 Mitogen-Activated Protein Kinases *
dc.subject.singlekeyword Tonsil *
dc.subject.singlekeyword Up-Regulation *
dc.title C4b-binding protein (C4BP) activates B cells through the CD40 receptor it
dc.type Articolo su rivista -
dc.type.circulation Rilevanza internazionale it
dc.type.contribution Articolo it
dc.type.driver info:eu-repo/semantics/article -
dc.type.full Pubblicazioni::01 - Articolo su rivista it
dc.type.impactfactor si it
dc.type.miur 262 en
dc.type.publicationstatus Pubblicato it
dc.type.referee Sì, ma tipo non specificato it
iris.isi.extIssued 2003 -
iris.isi.extTitle C4b-binding protein (C4BP) activates B cells through the CD40 receptor -
iris.isi.ideLinkStatusDate 2024/04/17 13:39:55 *
iris.isi.ideLinkStatusMillisecond 1713353995566 *
iris.orcid.lastModifiedDate 2026/03/20 11:00:06 *
iris.orcid.lastModifiedMillisecond 1774000806457 *
iris.scopus.extIssued 2003 -
iris.scopus.extTitle C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor -
iris.scopus.ideLinkStatusDate 2024/04/29 16:00:19 *
iris.scopus.ideLinkStatusMillisecond 1714399219113 *
iris.sitodocente.maxattempts 6 -
iris.unpaywall.bestoahost publisher *
iris.unpaywall.bestoaversion publishedVersion *
iris.unpaywall.doi 10.1016/s1074-7613(03)00149-3 *
iris.unpaywall.hosttype publisher *
iris.unpaywall.isoa true *
iris.unpaywall.journalisindoaj false *
iris.unpaywall.landingpage https://doi.org/10.1016/s1074-7613(03)00149-3 *
iris.unpaywall.metadataCallLastModified 26/03/2026 05:03:53 -
iris.unpaywall.metadataCallLastModifiedMillisecond 1774497833708 -
iris.unpaywall.oastatus bronze *
iris.unpaywall.pdfurl http://www.cell.com/article/S1074761303001493/pdf *
isi.authority.ancejournal IMMUNITY###1074-7613 *
isi.authority.sdg Goal 3: Good health and well-being###26522 *
isi.category NI *
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.affiliation -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.country -
isi.contributor.name - -
isi.contributor.name F -
isi.contributor.name LB -
isi.contributor.name AM -
isi.contributor.name E -
isi.contributor.name H -
isi.contributor.name A -
isi.contributor.name LD -
isi.contributor.name B -
isi.contributor.name E -
isi.contributor.name RS -
isi.contributor.researcherId EOU-3355-2022 -
isi.contributor.researcherId MUV-2278-2025 -
isi.contributor.researcherId FYV-2761-2022 -
isi.contributor.researcherId B-9607-2009 -
isi.contributor.researcherId DHN-0991-2022 -
isi.contributor.researcherId HVW-2263-2023 -
isi.contributor.researcherId C-8593-2011 -
isi.contributor.researcherId F-9718-2016 -
isi.contributor.researcherId DWS-4188-2022 -
isi.contributor.researcherId EBO-4052-2022 -
isi.contributor.researcherId EVZ-8124-2022 -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.subaffiliation -
isi.contributor.surname Brodeur -
isi.contributor.surname Angelini -
isi.contributor.surname Bacharier -
isi.contributor.surname Blom -
isi.contributor.surname Mizoguchi -
isi.contributor.surname Fujiwara -
isi.contributor.surname Plebani -
isi.contributor.surname Notarangelo -
isi.contributor.surname Dahlback -
isi.contributor.surname Tsitsikov -
isi.contributor.surname Geha -
isi.date.issued 2003 *
isi.description.abstracteng We demonstrate that the a. chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKgamma/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation. *
isi.description.allpeopleoriginal Brodeur, SR; Angelini, F; Bacharier, LB; Blom, AM; Mizoguchi, E; Fujiwara, H; Plebani, A; Notarangelo, LD; Dahlback, B; Tsitsikov, E; Geha, RS; *
isi.document.sourcetype WOS.SCI *
isi.document.type Article *
isi.document.types Article *
isi.identifier.doi 10.1016/S1074-7613(03)00149-3 *
isi.identifier.isi WOS:000183767700013 *
isi.journal.journaltitle IMMUNITY *
isi.journal.journaltitleabbrev IMMUNITY *
isi.language.original English *
isi.publisher.place 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA *
isi.relation.firstpage 837 *
isi.relation.issue 6 *
isi.relation.lastpage 848 *
isi.relation.volume 18 *
isi.title C4b-binding protein (C4BP) activates B cells through the CD40 receptor *
scopus.authority.ancejournal IMMUNITY###1074-7613 *
scopus.category 2723 *
scopus.category 2403 *
scopus.category 2725 *
scopus.contributor.affiliation Harvard Medical School -
scopus.contributor.affiliation Tor Vergata University -
scopus.contributor.affiliation Washington University -
scopus.contributor.affiliation Lund University -
scopus.contributor.affiliation Massachusetts General Hospital -
scopus.contributor.affiliation Osaka University -
scopus.contributor.affiliation University of Brescia -
scopus.contributor.affiliation University of Brescia -
scopus.contributor.affiliation Lund University -
scopus.contributor.affiliation Harvard Medical School -
scopus.contributor.affiliation Harvard Medical School -
scopus.contributor.afid 60030521 -
scopus.contributor.afid 60027509 -
scopus.contributor.afid 60010261 -
scopus.contributor.afid 60029170 -
scopus.contributor.afid 60029929 -
scopus.contributor.afid 60024322 -
scopus.contributor.afid 60015300 -
scopus.contributor.afid 60015300 -
scopus.contributor.afid 60029170 -
scopus.contributor.afid 60030521 -
scopus.contributor.afid 60030521 -
scopus.contributor.auid 6602083624 -
scopus.contributor.auid 56878283900 -
scopus.contributor.auid 57854930800 -
scopus.contributor.auid 35482393100 -
scopus.contributor.auid 57202125897 -
scopus.contributor.auid 59573953200 -
scopus.contributor.auid 7006165370 -
scopus.contributor.auid 34768650200 -
scopus.contributor.auid 7103328699 -
scopus.contributor.auid 6602749706 -
scopus.contributor.auid 35407026100 -
scopus.contributor.country United States -
scopus.contributor.country Italy -
scopus.contributor.country United States -
scopus.contributor.country Sweden -
scopus.contributor.country United States -
scopus.contributor.country Japan -
scopus.contributor.country Italy -
scopus.contributor.country Italy -
scopus.contributor.country Sweden -
scopus.contributor.country United States -
scopus.contributor.country United States -
scopus.contributor.dptid 110044144 -
scopus.contributor.dptid 113012509 -
scopus.contributor.dptid 112437110 -
scopus.contributor.dptid 109696706 -
scopus.contributor.dptid 113831527 -
scopus.contributor.dptid 113862523 -
scopus.contributor.dptid 103790640 -
scopus.contributor.dptid 103790640 -
scopus.contributor.dptid 109696706 -
scopus.contributor.dptid 110044144 -
scopus.contributor.dptid 110044144 -
scopus.contributor.name Scott R. -
scopus.contributor.name Federica -
scopus.contributor.name Leonard B. -
scopus.contributor.name Anna M. -
scopus.contributor.name Emiko -
scopus.contributor.name Hiroshi -
scopus.contributor.name Alessandro -
scopus.contributor.name Luigi D. -
scopus.contributor.name Bjorn -
scopus.contributor.name Erdyni -
scopus.contributor.name Raif S. -
scopus.contributor.subaffiliation Children's Hospital;Department of Pediatrics; -
scopus.contributor.subaffiliation Department of Pediatrics; -
scopus.contributor.subaffiliation Department of Pediatrics; -
scopus.contributor.subaffiliation Department of Clinical Chemistry; -
scopus.contributor.subaffiliation Department of Pathology; -
scopus.contributor.subaffiliation Department of Medicine; -
scopus.contributor.subaffiliation Department of Pediatrics;Inst. Molec. Med.;Angelo Nocivelli; -
scopus.contributor.subaffiliation Department of Pediatrics;Inst. Molec. Med.;Angelo Nocivelli; -
scopus.contributor.subaffiliation Department of Clinical Chemistry; -
scopus.contributor.subaffiliation Children's Hospital;Department of Pediatrics; -
scopus.contributor.subaffiliation Children's Hospital;Department of Pediatrics; -
scopus.contributor.surname Brodeur -
scopus.contributor.surname Angelini -
scopus.contributor.surname Bacharier -
scopus.contributor.surname Blom -
scopus.contributor.surname Mizoguchi -
scopus.contributor.surname Fujiwara -
scopus.contributor.surname Plebani -
scopus.contributor.surname Notarangelo -
scopus.contributor.surname Dahlback -
scopus.contributor.surname Tsitsikov -
scopus.contributor.surname Geha -
scopus.date.issued 2003 *
scopus.description.abstracteng We demonstrate that the α chain of human C4b binding protein (C4BP) binds directly to CD40 on human B cells at a site that differs from that used by CD40 ligand. C4BP induces proliferation, upregulation of CD54 and CD86 expression, and IL4-dependent IgE isotype switching in normal B cells but not in B cells from patients with CD40 or IKKγ/NEMO deficiencies. Furthermore, C4BP colocalized with B cells in the germinal centers of human tonsils. These observations suggest that C4BP is an activating ligand for CD40 and establish a novel interface between complement and B cell activation. *
scopus.description.allpeopleoriginal Brodeur S.R.; Angelini F.; Bacharier L.B.; Blom A.M.; Mizoguchi E.; Fujiwara H.; Plebani A.; Notarangelo L.D.; Dahlback B.; Tsitsikov E.; Geha R.S. *
scopus.differences scopus.publisher.name *
scopus.differences scopus.identifier.pmid *
scopus.differences scopus.description.allpeopleoriginal *
scopus.differences scopus.description.abstracteng *
scopus.document.type ar *
scopus.document.types ar *
scopus.funding.funders 100000060 - National Institute of Allergy and Infectious Diseases; 100000060 - National Institute of Allergy and Infectious Diseases; 100007197 - U.S. Public Health Service; 100007197 - U.S. Public Health Service; 501100000780 - European Commission; 501100000780 - European Commission; 501100004359 - Vetenskapsrådet; *
scopus.funding.ids T32AI007512; AI-31451; T32 AI-07512; QLG1-CT-2001-01536; *
scopus.identifier.doi 10.1016/S1074-7613(03)00149-3 *
scopus.identifier.pmid 12818164 *
scopus.identifier.pui 36776431 *
scopus.identifier.scopus 2-s2.0-0038503986 *
scopus.journal.sourceid 20798 *
scopus.language.iso eng *
scopus.publisher.name Cell Press *
scopus.relation.firstpage 837 *
scopus.relation.issue 6 *
scopus.relation.lastpage 848 *
scopus.relation.volume 18 *
scopus.title C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor *
scopus.titleeng C4b-Binding Protein (C4BP) Activates B Cells through the CD40 Receptor *
Appare nelle tipologie: 01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/57263
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 116
  • ???jsp.display-item.citation.isi??? 108
social impact